April 16, 2007
Skinvisible's Marketing Partner EMD Chemicals Inc., an Affiliate of Merck KGaA, Darmstadt, Germany, to Profile Invisicare® at In-Cosmetics in Paris
LAS VEGAS, and PARIS, April 16, 2007 - Skinvisible Pharmaceuticals, Inc., a wholly owned subsidiary of Skinvisible, Inc. (OTC Bulletin Board: SKVI / Website: www.skinvisible.com) is pleased to announce that its marketing partner, EMD Chemicals Inc., an affiliate of Merck KGaA, Darmstadt, Germany, will exhibit the Invisicare delivery technology at the "In-Cosmetics" exhibition in Paris, France, April 17 - 19th, 2007.
The In-Cosmetics event, held annually in Europe, profiles companies with raw materials and ingredients in the cosmetics, toiletries and personal care industry. Along with these suppliers, the event attracts R&D, production and marketing specialists from pharmaceutical and cosmeceutical companies around the world.
EMD Chemicals Inc. ("EMD / Merck KGaA") has an exclusive worldwide sales, collaboration and distribution agreement for the personal care market involving Skinvisible's patented polymer-based topical delivery vehicle, Invisicare.
"The In-Cosmetics event in Paris will provide a great opportunity for Invisicare to be presented by our marketing partner to this important sector of the cosmetics, toiletries and personal care industry," said Mr. Terry Howlett, President and CEO of Skinvisible, Inc. "Our scientific research has proven the ability of Invisicare to hold active ingredients to the skin for long periods of time while still allowing the skin to breath, and we believe that advantage is a value-added for any topical skin care product. We are very excited to have our partner EMD / Merck KGaA meeting one-on-one with international decision-makers who potentially can benefit from incorporating our polymer delivery system into their product."
Skinvisible's business model is focused on licensing its proprietary formulations with Invisicare to pharmaceutical and cosmeceutical companies as well as assisting companies in revitalizing or enhancing their existing skin care products.
About Invisicare®
Skinvisible has patented its technology and trademarked its polymer delivery system, Invisicare. Invisicare is a combination of hydrophilic and hydrophobic polymers that hold active ingredients on the skin for extended periods of time. They are non-occlusive and allow normal skin respiration and perspiration while moisturizing and protecting against exposure from a wide variety of environmental irritants. See: www.invisicare.com
About Skinvisible Pharmaceuticals, Inc.
Headquartered in Las Vegas, Nevada, Skinvisible Pharmaceuticals is a research-and-development company whose primary business objective is to license its technology and formulated products to manufacturers of Rx and OTC skincare products. See www.skinvisible.com
About EMD Chemicals Inc.
EMD Chemicals represents the North American chemical sector of Merck KGaA, Darmstadt, Germany. As an international organization with 1,100 employees and revenues of more than $US 350 million, EMD Chemicals focuses on specialty chemicals for pharmaceutical, biotech, cosmetic, agricultural, automotive, plastics, electronics and other industrial applications.
About Merck KGaA, Darmstadt, Germany
Merck is a global pharmaceutical and chemical company with sales of EUR 6.3 billion in 2006, a history that began in 1668, and a future shaped by about 35,000 employees (including Merck Serono) in 56 countries. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.
Forward-Looking Statements
This press release contains 'forward looking' statements within the meaning of Section 21A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and are subject to the safe harbors created thereby. Such statements involve certain risks and uncertainties associated with an emerging company. Actual results could differ materially from those projected in the forward looking statements as a result of risk factors discussed in Skinvisible, Inc. reports on file with the U.S. Securities and Exchange Commission (including, but not limited to, a report on Form 10K for the year ending December 31, 2006.)
|
Press Release Index
New Press Release Alerts:
Click here to join our mailing list.
|
Skinvisible Web